Our chart of the month looks at CONMED's 10-year sales history in sports medicine in the wake of reports that the company could be for sale.

CONMED Reportedly Weighing Decision on Future

Our chart of the month looks at CONMED’s 10-year sales history in sports medicine in the wake of reports that the company could be for sale.

A quarterly recap of hip product launches

Stryker Gaining Ground in OUS Hip Replacement Market

Our chart of the month looks at the ten-year sales history for OUS hip replacement among Zimmer Biomet, Stryker and DePuy Synthes.

Highlights from the brand new 2026 edition include the health of end markets, dynamics at play in the trauma segment, and the tantalizing promise of orthobiologics.

Takeaways from THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT

Highlights from the brand new 2026 edition include the health of end markets, dynamics at play in the trauma segment, and the tantalizing promise of orthobiologics.

Orthoflash®
GMReis VersaLock Tibial Plateau Plating
GMReis Earns 510(k) for 3.5mm VersaLock Tibial Plateau Plating

The clearance expands the VersaLock trauma platform, providing anatomically designed titanium implants featuring ±15° variable-angle locking technology and 3.5 mm dynamic compression.

,
Medacta NextAR Hip
Medacta Introduces NextAR Hip Application

The platform integrates patient-specific, real-time data into the operative workflow, enhancing accuracy while allowing for personalized adjustments.

,
MolecuLight
Study Evaluates Fluorescence Imaging in Orthopedic Surgery

The study reports the first clinical evidence supporting use of the MolecuLightDX imaging device during revision knee arthroplasty for periprosthetic joint infection.

,
CarboFix CarboClear Hybrid MIS Pedicle Screw
CarboFix Spine Launches CarboClear Hybrid MIS Pedicle Screw

The new MIS solution delivers surgical efficiency while maintaining the imaging and clinical advantages of carbon fiber-reinforced technology.

,
Synergy Spine's Synergy Disc
Synergy Disc Reaches 100 US Cases in 100 Days

The milestone comes within 100 days of its first commercial U.S. procedure, reflecting early surgeon adoption of a motion-preserving alternative to traditional fusion.

,
Competitive Landscape
Industry Voices

Contact Us

  • This field is for validation purposes and should be left unchanged.

0